News
Inovio, Advaccine receive regulatory nod for two heterologous prime-boost trials in China using Covid-19 DNA vaccine candidate, INO-4800
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, announced that it has received regulatory allowance for two clinical trials investigating heterologous boosting...
Drug Research
Seagen and RemeGen enter up to $2.6bn deal for cancer drug
Seagen and a Chinese company, RemeGen, have signed an exclusive global licencing agreement to develop and market a new HER2-targeted antibody-drug conjugate (ADC), disitamab vedotin.
Merging Seagen’s drug-linker technology with RemeGen’s new HER2 antibody, disitamab vedotin selectively carries the anti-cancer...
News
Sharp Appoints New Business Development Manager for UK Commercial Services
Sharp, a part of UDG Healthcare and a leading provider of pharmaceutical packaging and clinical services, has appointed Paul Thomas as Business Development Manager for its UK commercial services.
Reporting to Jeff Benedict, Chief Commercial Officer at Sharp, Paul has...
News
DFE Pharma demonstrates Impact of Powder Properties on the Rheological Behavior of Excipients
DFE Pharma, a global leader in pharmaceutical excipient solutions, is continuously supporting relevant scientific research and innovations in its field.
With the recent publication of a new study demonstrating the impact of powder properties on the rheological behavior of excipients,...
Drug Research
Heraeus completes multi-million Euro cancer therapy API capacity expansion
Heraeus Pharmaceutical Ingredients’ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs) is now fully operational at the company’s headquarters in Hanau, Germany.
Heraeus, a business line of Heraeus Precious Metals, is the leading global market supplier...
News
KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to manufacture generic product for filing in Japan
KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals for the manufacturing of a generic product for filing in Japan. KYOWA will be the first...
News
Metrics Contract Services Appoints Senior Director of Scientific and Technical Affairs
Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, welcomes Anshul Gupte, PhD as Senior Director, Scientific and Technical Affairs.
In that capacity, Anshul will be responsible for technical and scientific oversight of client projects. He...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















